Published in Cancer Weekly, May 13th, 2008
"We found that expression of exogenous reporters (LUC and EGFP) was specifically inhibited in tumor cells but...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-05-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.